Front Row Advisors LLC Astrazeneca PLC Transaction History

Front Row Advisors LLC

$265 Million
Q1 2024

A detailed history of Front Row Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Front Row Advisors LLC holds 161 shares of AZN stock, worth $12,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares

161

Holding current value

$12,343

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $9,825 - $11,200	161 New	161 $10,000
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $778 - $860	12 Added 7.1%	181 $12,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1,887 - $2,046	-27 Reduced 13.78%	169 $12,000
Q1 2023 May 22, 2023	BUY	$63.15 - $71.6 $11,493 - $13,031	182 Added 1300.0%	196 $14,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $11,114 - $12,601	-176 Reduced 92.63%	14 $20,000

Q4 2022 Feb 15, 2023	SELL	$54.21 - $70.44 $3,144 - $4,085	-58 Reduced 23.39%	190 $13,000
Q3 2022 Nov 15, 2022	SELL	$53.02 - $135.75 $11,558 - $29,593	-218 Reduced 46.78%	248 $14,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $3,081 - $3,699	-52 Reduced 10.04%	466 $31,000
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $390 - $469	7 Added 1.37%	518 $34,000
Q4 2021 Mar 09, 2022	SELL	$54.02 - $63.83 $1,080 - $1,276	-20 Reduced 3.77%	511 $30,000
Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $1,000 - $1,094	18 Added 3.51%	531 $32,000
Q2 2021 Aug 23, 2021	BUY	$48.42 - $60.18 $11,039 - $13,721	228 Added 80.0%	513 $30,000
Q1 2021 Apr 28, 2021	BUY	$47.16 - $54.44 $660 - $762	14 Added 5.17%	285 $14,000
Q4 2020 Feb 25, 2021	BUY	$48.52 - $58.02 $533 - $638	11 Added 4.23%	271 $14,000
Q3 2020 Nov 30, 2020	BUY	$53.07 - $61.1 $8,225 - $9,470	155 Added 147.62%	260 $14,000
Q2 2020 Aug 17, 2020	SELL	$43.1 - $55.31 $215 - $276	-5 Reduced 4.55%	105 $6,000
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $302 - $410	-8 Reduced 6.78%	110 $6,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $679 - $807	16 Added 15.69%	118 $6,000
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $2,005 - $2,273	50 Added 96.15%	102 $5,000
Q2 2019 Aug 27, 2019	BUY	$37.28 - $41.68 $596 - $666	16 Added 44.44%	52 $2,000
Q4 2017 Feb 01, 2018	BUY	$32.09 - $34.78 $1,155 - $1,252	36	36 $1,000

Others Institutions Holding AZN

# of Institutions

1,250

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

Price T Rowe Associates Inc Baltimore, MD

61.3M
Shares

$4.7 Billion
0.51% of portfolio
Wellington Management Group LLP Boston, MA

49.1M
Shares

$3.77 Billion
0.6% of portfolio
Primecap Management CO Pasadena, CA

42.9M
Shares

$3.29 Billion
2.21% of portfolio
Capital International Investors Los Angeles, CA

34.5M
Shares

$2.65 Billion
0.48% of portfolio
Jennison Associates LLC

17.3M
Shares

$1.32 Billion
0.79% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $238B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account